Self Employed noted that GSK's mRNA candidate posted higher immune responses than standard and high-dose comparators in a phase 2 trial.
Public source
Publisher name
Public post
Despite yesterday's news about setbacks in mRNA technology for cancer, we're seeing dramatic improvements in areas like the flu vaccine, where efficacy has historically…
Company
Self Employed
Helping you get through your work day, one post at a time!
- Industry
- Education
- Location
- Satellite Beach, US
- Company size
- 10,001+ employees
About Self Employed
The world's largest independent community for freelancers, entrepreneurs, and self employed professionals. Self Employed is an independent media company, backed by Zefs Capital.
See moreLatest activity
Latest activity from Self Employed
102 signals
Legal & Regulatory
Self Employed noted that Ofgem's data centre milestones may bite at 1MW, not 10MW, and that the draft CUSC text does not set a threshold for queue management milestones above 10MW rated IT load.
Strategy & Corporate Development
Self Employed provides self-employed workers with a platform to manage their time and work
Strategy & Corporate Development
Self Employed provides consulting, accounting, and legal services.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Self-Employed
Self-Employed published new research showing pupils engage with AI tutors for just two minutes weekly unless a human is present.
Research & Knowledge
Gates Medical Research Institute
Gates Medical Research Institute published a Medscape piece on the progress of the Phase 3 clinical trial of M72/AS01E, which may have the potential to be the first new TB vaccine in more than a century.
Research & Knowledge
Elion Medical Communications
Elion Medical Communications noted that the results represent the first positive phase 3 findings for an individualised mRNA-based cancer treatment.
Research & Knowledge
Garvan Institute of Medical Research
Garvan Institute of Medical Research published a study in Nature showing functional chimeric mRNAs encode proteins in mammalian immunity, with collaboration with Ruaidhrí Jackson at Harvard Medical School and Moderna.
Research & Knowledge
Unbiased Science